AtriCure Inc (ATRC.OQ)
ATRC.OQ on NASDAQ Stock Exchange Global Market
9.80USD
10:38am EDT
9.80USD
10:38am EDT
Price Change (% chg)
$0.14 (+1.45%)
$0.14 (+1.45%)
Prev Close
$9.66
$9.66
Open
$9.69
$9.69
Day's High
$9.80
$9.80
Day's Low
$9.69
$9.69
Volume
2,914
2,914
Avg. Vol
24,186
24,186
52-wk High
$10.00
$10.00
52-wk Low
$5.90
$5.90
About
AtriCure, Inc., is a medical device company. The Company develops, manufactures and sells cardiac surgical ablation systems designed to create lesions, or scars, in cardiac, or heart, tissue and devices for the exclusion of the left atrial appendage. The Company has two primary product lines for the ablation of cardiac tissue.... (more)
Overall
| Beta: | 1.48 |
| Market Cap (Mil.): | $202.20 |
| Shares Outstanding (Mil.): | 20.93 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ATRC.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 27.50 | 37.76 |
| EPS (TTM): | -0.46 | -- | -- |
| ROI: | -22.38 | 9.26 | 18.76 |
| ROE: | -29.51 | 12.54 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Johnson & Johnson (JNJ.N) | $93.93 | +0.43 |
| Medtronic, Inc. (MDT.N) | $55.32 | +0.08 |
| St. Jude Medical, Inc. (STJ.N) | $52.89 | +0.50 |
| Stryker Corporation (SYK.N) | $71.04 | +0.58 |
| Abbott Laboratories (ABT.N) | $36.90 | +0.27 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

